TITLE

Systolic Heart Failure in a Patient With Hypertrophic Obstructive Cardiomyopathy

AUTHOR(S)
Whitten, Shannon Etheridge
PUB. DATE
October 2008
SOURCE
Critical Care Nurse;Oct2008, Vol. 28 Issue 5, p44
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information on hypertrophic obstructive cardiomyopathy, a genetically transmitted disease. Complications of the disease include heart failure, atrial and ventricular arrhythmia and sudden cardiac death. Options for patients who do not respond to medication like percutaneous transluminal septal myocardial ablation and surgical myectomy are also explored.
ACCESSION #
34590040

 

Related Articles

  • High prevalence of Arginine to Glutamine Substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians. Selvi Rani, Deepa; Nallari, Pratibha; Priyamvada, Singh; Narasimhan, Calambur; Singh, Lalji; Thangaraj, Thangaraj // BMC Medical Genetics;2012, Vol. 13 Issue 1, p69 

    Background: Troponin I (TNNI3) is the inhibitory subunit of the thin filament regulatory complex Troponin, which confers calcium-sensitivity to striated muscle actomyosin ATPase activity. Mutations (2-7%) in this gene had been reported in hypertrophic cardiomyopathy patients (HCM). However, the...

  • Insights and challenges in hypertrophic cardiomyopathy, 2012. Sen-Chowdhry, Srijita; Tomé Esteban, María Teresa; McKenna, William J. // Herzschrittmachertherapie und Elektrophysiologie;Sep2012, Vol. 23 Issue 3, p174 

    We present a contemporary overview of hypertrophic cardiomyopathy (HCM), incorporating recent thinking on disease mechanisms and advances in therapy. Clinical, pathological, genetic, and mechanistic definitions of HCM are discussed. The genetic profile of HCM in both adults and children is...

  • Almanac 2011: Cardiomyopathies. Elliott, Perry M.; Mohiddin, Saidi A. // Kardio List;Jan2012, Vol. 7 Issue 1/2, p14 

    The article offers clinical information on cardiomyopathies, myocardial disorders in which the heart muscle is structurally and functionally abnormal but without coronary artery disease, hypertension or valvular disease. It defines hypertrophic cardiomyopathy (HCM), sudden cardiac death,...

  • Fragmented QRS as a predictor of arrhythmic events in patients with hypertrophic obstructive cardiomyopathy. Femenía, Francisco; Arce, Maurico; Grieken, Jorge; Trucco, Emilce; Mont, Luis; Abello, Mauricio; Merino, José; Rivero-Ayerza, Máximo; Gorenek, Bulent; Rodriguez, Carlos; Hopman, Wilma; Baranchuk, Adrian // Journal of Interventional Cardiac Electrophysiology;Dec2013, Vol. 38 Issue 3, p159 

    Objectives: This study aims to determine whether fragmented QRS (fQRS) in the surface electrocardiogram (ECG) at implantable cardioverter defibrillator (ICD) implant can predict arrhythmic events using appropriate therapy delivered by the ICD as a surrogate. Background: Hypertrophic obstructive...

  • Yield of Genetic Testing in Hypertrophic Cardiomyopathy. van Driest, Sara L.; Ommen, Steve R.; Tajik, A. Jamil; Gersh, Bernard J.; Ackerman, Michael J. // Mayo Clinic Proceedings;Jun2005, Vol. 80 Issue 6, p739 

    OBJECTIVE: To determine the clinical parameters of hypertrophic cardiomyopathy (HCM) that correlated significantly with the presence of an identifiable sarcomeric mutation. PATIENTS AND METHODS: Previous comprehensive mutational analyses of all protein-coding exons of 8 sarcomeric genes revealed...

  • Hypertrophic cardiomyopathy: current understanding and treatment objectives. G S Soor // Journal of Clinical Pathology;Mar2009, Vol. 62 Issue 3, p226 

    The understanding of hypertrophic cardiomyopathy (HCM) has changed dramatically over the last few decades, and it is now understood to be caused by a mutation in one of several cardiac sarcomeric genes. Due to complications such as outflow tract obstruction, diastolic dysfunction, arrhythmias,...

  • Apical hypertrophic cardiomyopathy with aneurysmal degeneration of the apex. Sato, Akira; Shiga, T.; Kawarai, Hirotaka; Matsuda, Naoki; Kimura, Fumiko; Sakai, Fumikazu; Kasanuki, Hiroshi // Heart & Vessels;Feb2003, Vol. 18 Issue 1, p53 

    The article presents information on case involving a 36-year-old Japanese woman who had previously been diagnosed with apical hypertrophic cardiomyopathy. Amiodarone therapy was started to prevent ventricular tachyarrhythmia. However, she discontinued amiodarone at the end of 1988 and stopped...

  • PREVALENCE AND SIGNIFICANCE OF T WAVE INVERSIONS ON THE 12 LEAD ECG IN 1400 JUNIOR ELITE ATHLETES COMPETING AT REGIONAL AND NATIONAL LEVEL. Makan, J.; Sharmo, S.; Whyte, G.; Patel, J.; McKenna, W. J. // Heart;May2004 Supplement 2, Vol. 90, pA60 

    The article presents a study to detect the prevalence and significance of T wave inversions on the 12 lead ECG in 1400 junior elite athletes. Highly trained athletes exhibit certain ECG changes that resemble those seen in patients with hypertrophic cardiomyopathy (HCM) and arrhythmogenic right...

  • Update on Hypertrophic Cardiomyopathy. Marian, Ali J. // Texas Heart Institute Journal;2010, Vol. 37 Issue 3, p322 

    The article presents an update on hypertrophic cardiomyopathy (HCM), presented at the 9th Texas Update in Cardiovascular Advancements held in Houston, Texas on December 4 and 5, 2009. As defined, HCM is a primary disease of cardiac myocytes, characterized mainly by cardiac and myocyte...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics